Zobrazeno 1 - 10
of 201
pro vyhledávání: '"J. García de Yébenes"'
Autor:
E. Rodríguez-Almaraz, E. Gutiérrez-Solís, E. Rabadán, P. Rodríguez, M. Alonso, L. Carmona, M. J. García de Yébenes, E. Morales, M. Galindo-Izquierdo
Publikováno v:
European Journal of Medical Research, Vol 28, Iss 1, Pp 1-9 (2023)
Key messages 1. Development a prognostic index of poor renal evolution in patients with LN. 2. We use clinical, histological and laboratory factors 6 months after diagnosis and treatment 3. Effective tool in the early detection and management, easy t
Externí odkaz:
https://doaj.org/article/b0c60c6af8d14a8eb22fe89b122b5fae
Autor:
E. Rodríguez-Almaraz, E. Gutiérrez-Solís, E. Rabadán, P. Rodríguez, M. Alonso, L. Carmona, M. J. García de Yébenes, E. Morales, M. Galindo-Izquierdo
Background Currently we do not have an ideal biomarker in lupus nephritis (LN) that should help us to identify those patients with SLE at risk of developing LN or to determine those patients at risk of renal progression. We aimed to evaluate the deve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c19a05945a7a32a50df00c8e34b661a8
https://doi.org/10.21203/rs.3.rs-1886411/v1
https://doi.org/10.21203/rs.3.rs-1886411/v1
Autor:
María J. García de Yébenes, Pablo Lázaro y de Mercado, Kathryn Fitch-Warner, Javier Belaza-Santurde
Publikováno v:
Revista Española de Cardiología. 59:1232-1243
Introduccion y objetivos Hay evidencia de variabilidad geografica en el uso de tecnologias medicas no explicada por diferencias en la carga de enfermedad. El objetivo de este trabajo es describir la variabilidad entre comunidades autonomas en el uso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a2b2a15c5dd76428d1d98cf9b7048331
https://doi.org/10.1157/13096594
https://doi.org/10.1157/13096594
Autor:
Kathryn Fitch-Warner, Javier Belaza-Santurde, María J. García de Yébenes, Pablo Lázaro y de Mercado
Publikováno v:
Revista Española de Cardiología (English Edition). 59:1232-1243
Introduction and objectives There is evidence that some geographic variations in the use of medical technologies are not explained by differences in disease burden. The objectives of this study were to quantify variability in the use of percutaneous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6301380d994cc1d2beab4fa07d54915f
https://doi.org/10.1016/s1885-5857(07)60079-6
https://doi.org/10.1016/s1885-5857(07)60079-6
Autor:
J. Menéndez, Jose A. Rodriguez-Navarro, J. García de Yébenes, Maria Angeles Mena, C. Correa, María José Casarejos, Rosa M. Solano
Publikováno v:
Journal of Neurochemistry. 94:1005-1014
l-DOPA is the most effective treatment for Parkinson's disease but in isolated neuronal cultures it is neurotoxic for dopamine (DA) neurones. Experiments in vivo and clinical studies have failed to show toxicity of l-DOPA in animals or patients but t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::39f8486bedb4c21ca2e94d8cccc7d88b
https://doi.org/10.1111/j.1471-4159.2005.03249.x
https://doi.org/10.1111/j.1471-4159.2005.03249.x
Autor:
Blas Morales, J. García de Yébenes, Israel Ampuero, J. de Dios Luna del Castillo, Francisco J. Barrero, Janet Hoenicka, Francisco Vives
Publikováno v:
The Pharmacogenomics Journal. 5:135-141
Depression is a common symptom in Parkinson's disease (PD) and it is present in up to 40% of the patients. The cause of depression in PD is thought to be related to disturbance of monoamine neurotransmission. The endogenous cannabinoid system mediate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0398432fefd769adb823ff2eb11ff02
https://doi.org/10.1038/sj.tpj.6500301
https://doi.org/10.1038/sj.tpj.6500301
Autor:
P J García Ruiz, E. Ulmer, Carlos Cenjor, R. Sanchez Pernaute, J García de Yébenes, A. Fontán, E. Gomez Tortosa, A. Rojo
Publikováno v:
Der Nervenarzt. 72:437-440
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d1257a2fcacc0835c6c8e4fec1daa5f
https://doi.org/10.1007/s001150050775
https://doi.org/10.1007/s001150050775
Publikováno v:
Journal of Neural Transmission. 106:1105-1123
Recent experiments have shown that glia-conditioned medium (GCM) protects against L-3,4-Dihydroxyphenylalanine (L-DOPA) toxicity for dopamine neurons in culture. In this study we have investigated the effect of GCM on the number of tyrosine hydroxyla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c031a7e005a883f5c6296030083f0ba0
https://doi.org/10.1007/s007020050227
https://doi.org/10.1007/s007020050227
Autor:
Isabel Rubio, J García de Yébenes
Publikováno v:
Revista Clínica Española. 206:573-575
El deposito de amiloide en el cerebro produce enfermedades neurologicas caracterizadas por demencia. Esos depositos estan constituidos por proteinas fibrilares con conformacion β-planar cuyo origen es debido a mutaciones, infecciones o alteraciones
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bfab3f9062ec95551cd34d1fe9d12219
https://doi.org/10.1157/13096306
https://doi.org/10.1157/13096306
Autor:
J García de Yébenes, D. Garcia Urra, E. Varela de Seijas, Pedro J. Garcia-Ruiz, Blas Morales, Félix Javier Jiménez-Jiménez, Antonio Santiago Río Vázquez
Publikováno v:
European Journal of Neurology. 4:498-501
Calcium channel blockers can act on dopaminergic systems, and some reports suggest that they could be useful for the treatment of several movement disorders. In order to assess the efficacy of nicardipine in tics disorders we performed a prospective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e6f770439062599fec45b6f40090a57
https://doi.org/10.1111/j.1468-1331.1997.tb00390.x
https://doi.org/10.1111/j.1468-1331.1997.tb00390.x